February 27, 2024
PMDA Chief Executive Yasuhiro Fujiwara (left) Panelists talked over ways to attract US-based emerging biopharma (EBP) companies to Japan to counter drug lags and losses at a symposium held by the Japanese Society of Medical Oncology (JSMO) on February 24...read more